ERMA.ST
Enorama Pharma AB
Price:  
3.26 
SEK
Volume:  
13,628.00
Sweden | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ERMA.ST WACC - Weighted Average Cost of Capital

The WACC of Enorama Pharma AB (ERMA.ST) is 5.4%.

The Cost of Equity of Enorama Pharma AB (ERMA.ST) is 5.45%.
The Cost of Debt of Enorama Pharma AB (ERMA.ST) is 7.00%.

Range Selected
Cost of equity 4.60% - 6.30% 5.45%
Tax rate 20.60% - 20.90% 20.75%
Cost of debt 7.00% - 7.00% 7.00%
WACC 4.6% - 6.3% 5.4%
WACC

ERMA.ST WACC calculation

Category Low High
Long-term bond rate 2.5% 3.0%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.3 0.37
Additional risk adjustments 0.5% 1.0%
Cost of equity 4.60% 6.30%
Tax rate 20.60% 20.90%
Debt/Equity ratio 0 0
Cost of debt 7.00% 7.00%
After-tax WACC 4.6% 6.3%
Selected WACC 5.4%